Index Catalog // Arch : Northwestern University Institutional Repository

Start Over

Filtering by: Keyword Glioblastoma Subject Molecular biology

1 - 2 of 2

List Gallery Masonry Slideshow

Defining and Therapeutically Targeting IDH1-WT Oncogenicity in GBM

Description:

Glioblastoma multiforme (GBM) is the most prevalent primary central nervous system tumor, characterized by resistance to therapeutic intervention, inevitable recurrence, and ultimately patient death. The dismal prognosis is due in part to underlying molecular factors that promote an intratumoral cellular state heterogeneity and protect tumor cells from cell death pathways....

Keyword:

Ferroptosis, Glioblastoma, Cancer, Stemness, Metabolism, and IDH1

Subject:

Molecular biology, Medicine, and Neurosciences

Creator:

Murnan, Kevin Michael

Owner:

Scholarly Digital Publishing

Language:

en

Date Uploaded:

06/22/2022

Date Created:

2022-01-01

Resource Type:

Dissertation

Alternate Identifier:

http://dissertations.umi.com/northwestern:15885 and etdadmin_upload_865864
LY6K Promotes Glioblastoma Tumorigenicity via CAV-1-Mediated ERK1/2 Signaling Enhancement

Description:

Background: Glioblastoma (GBM) tumors are the most malignant brain cancers and are characterized as Grade IV astrocytomas by the World Health Organization. GBM tumors can be classified into three molecular subtypes known as proneural, classical, and mesenchymal. In addition, GBM tumors also have a small population of cells known as...

Keyword:

LY6K, Methylation, Glioblastoma, ERK1/2, and CAV-1

Subject:

Molecular biology, Oncology, and Neurosciences

Creator:

Sastry, Namratha G

Owner:

Scholarly Digital Publishing

Language:

en

Date Uploaded:

01/21/2021

Date Created:

2020-01-01

Resource Type:

Dissertation

Alternate Identifier:

etdadmin_upload_733180 and http://dissertations.umi.com/northwestern:15049

LIBRARIES | ARCH

Limit your search

Type

Resource type

Creator

Keyword

Subject

Language

Defining and Therapeutically Targeting IDH1-WT Oncogenicity in GBM

LY6K Promotes Glioblastoma Tumorigenicity via CAV-1-Mediated ERK1/2 Signaling Enhancement

Limit your search

Search Constraints

Search Results